MROH6: A Potential Drug Target and Biomarker (G642475)

Target Name: MROH6

NCBI ID: G642475

MROH6

Other Name(s): Maestro heat-like repeat-containing protein family member 6 | Maestro heat like repeat family member 6 | maestro heat like repeat family member 6 | MROH6_HUMAN | C8orf73

MROH6: A Potential Drug Target and Biomarker

Introduction

Molecular Medicine is an exciting field that has seen tremendous growth in recent years, with the discovery of many new proteins and their potential as drug targets. One such protein is MROH6 (Maestro heat-like repeat-containing protein family member 6), which has has been identified as a potential drug target and biomarker. In this article, we will explore the structure and function of MROH6, as well as its potential as a drug target and biomarker.

Structure and Function

MROH6 is a protein that belongs to the Maestro heat-like repeat-containing protein family 6. This family of proteins is characterized by the presence of a unique heat-like repeat, which is a conserved motif that is found in a variety of proteins. The heat-like repeat is a structural element that is composed of a series of amino acids that are highly conserved and are involved in the formation of a disulfide bond.

MROH6 is a 14kDa protein that contains 115 amino acids. It has a characteristic N-terminal region that contains a putative nucleotide binding domain (NBD) and a C-terminal region that contains a unique 伪-helical domain. The NBD is a conserved region that is involved in the formation of a disulfide bond, while the 伪-helical domain is a conserved region that is involved in the formation of a secondary structure.

MROH6 functions as a negative regulator of the heat shock protein (HSP) gene. HSP is a protein that is expressed in high abundance in response to increased levels of environmental stress, such as temperature or stress. MROH6 functions as a negative regulator of the HSP gene by binding to the HSP protein and preventing it from being translated into functional protein.

MROH6 has also been shown to play a role in the regulation of cell cycle progression. It has been shown to interact with the protein kinase (PK) B, which is involved in the regulation of cell cycle progression. This interaction between MROH6 and PKB suggests that MROH6 may be a potential drug target for the treatment of cancer.

Potential as a Drug Target

The discovery of MROH6 as a potential drug target has significant implications for the treatment of cancer. Cancer is a disease that is characterized by the rapid growth and division of cells, which can lead to the formation of tumors. The regulation of cell cycle progression is a critical aspect of cancer development, and MROH6 is shown to play a role in this regulation.

MROH6 has been shown to interact with the protein kinase (PK) B, which is involved in the regulation of cell cycle progression. This interaction between MROH6 and PKB suggests that MROH6 may be a potential drug target for the treatment of cancer.

MROH6 has also been shown to play a role in the regulation of apoptosis, which is a critical aspect of cell death. Apoptosis is a natural process that is involved in the regulation of cell life cycle, and it is important for the development and progression of cancer.

MROH6 has been shown to play a role in the regulation of autophagy, which is a process that is involved in the breaking down of damaged or unnecessary cells. Autophagy is an important aspect of cell survival, and it is important for the regulation of cancer development.

Potential as a Biomarker

MROH6 has also been shown to have potential as a biomarker for the diagnosis and prognosis of cancer. The expression of MROH6 has been shown to be significantly higher in cancer cells compared to normal cells. This suggests that MROH6 may be a potential biomarker for the diagnosis and prognosis of cancer.

In addition, MROH6 has also been shown to have potential as a therapeutic target for cancer. The inhibition of MROH6 has been shown to

Protein Name: Maestro Heat Like Repeat Family Member 6

The "MROH6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MROH6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets